U.S. economic data shows flat retail sales and weak labor growth, fueling recession fears. Alphabet and SpaceX/xAI face leadership exits and massive AI debt. Meanwhile, Trump officials face Epstein scandals, and Taiwan rejects U.S. semiconductor relocation goals.

Duke Energy surpassed 2025 expectations with $6.31 EPS. The firm raised its five-year capital plan to $103 billion, targeting 9.6% growth driven by data center demand and grid upgrades. Management projects 5%–7% long-term EPS growth, aiming for the top half starting in 2028.

Hasbro’s Playing to Win strategy drove a 14% revenue increase in 2025, fueled by record Wizards of the Coast growth. Despite tariff headwinds and a goodwill impairment, the company reached 1 billion fans. A new $1 billion share repurchase and AI-driven innovation anchor 2026.

Coca-Cola reported 5% organic revenue growth for 2025, with comparable EPS hitting $3.00. Leadership transitions smoothly as Enrique Braun becomes CEO. 2026 guidance forecasts 4–5% revenue and 7–8% EPS growth, despite volume pressure in Mexico and divestiture headwinds in Africa.

Marriott International reported strong 2025 results, with RevPAR rising 2% and net rooms increasing 4.3%. International markets and luxury brands led growth. The company returned $4B to shareholders and projects higher EBITDA and a record development pipeline for 2026.

S&P Global reported 9% revenue growth for Q4 2025, driven by strong ratings and indices performance. Despite an EPS miss, the firm raised dividends for a 53rd year. Strategy focuses on AI automation, private markets, and the upcoming Mobility Global spin-off in 2026.

Quest Diagnostics reported $11.04 billion in 2025 revenue. For 2026, the firm forecasts adjusted EPS of $10.50–$10.70 and revenue growth up to 7.1%. Despite weather headwinds in January, growth is supported by expanded networks and the Corewell Health partnership.

CVS Health reported strong FY2025 revenue exceeding $400B and adjusted EPS of $6.75. Despite Medicare Advantage margin risks and litigation charges, the company expects growth in 2026. Key drivers include Aetna’s recovery, PBM transparency, and retail pharmacy expansion.

Barclays' 2025 report highlights a diversified business model focused on operational efficiency and digital transformation via AI. The Group targets a 14% RoTE by 2028 while facilitating £1tn in sustainable finance. Key risks include climate change, cybersecurity, and macroeconomic volatility.

Philips reported strong 2025 results with Q4 order intake and sales both up 7%. Leadership expects 3–4.5% sales growth for 2026, driven by innovation and North American demand. To counter tariff headwinds, the company launched a new €1.5 billion productivity program.